PP_1170x120_10-25-21

BARDA

Regeneron inks manufacturing and supply agreement with BARDA and U.S. Department of Defense for REGN-COV2 anti-viral antibody cocktail

Regeneron inks manufacturing and supply agreement with BARDA and U.S. Department of Defense for REGN-COV2 anti-viral antibody cocktail

TARRYTOWN, N.Y. —  Regeneron Pharmaceuticals announced Tuesday that, as part of Operation Warp Speed, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, and the Department of Defense Joint Program Executive Office for Chemical, Biological,

Johnson & Johnson is a leading candidate for COVID-19 vaccine

Johnson & Johnson is a leading candidate for COVID-19 vaccine

NEW BRUNSWICK, N.J. – Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between the Janssen Pharmaceutical Companies of Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA); and the rapid scaling of